<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82475">
  <stage>Registered</stage>
  <submitdate>17/12/2007</submitdate>
  <approvaldate>14/02/2008</approvaldate>
  <actrnumber>ACTRN12608000087358</actrnumber>
  <trial_identification>
    <studytitle>Effects of tetrahydrobiopterin(BH4) in patients with angina</studytitle>
    <scientifictitle>Effects of tetrahydrobiopterin (BH4) on myocardial blood flow and vascular function in coronary artery disease.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Coronary artery disease</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Folic acid (20 mg/day) and tetrahydrobiopterin (5 mg/kg/day) for 14 days</interventions>
    <comparator>Placebo- (D-glucose anhydrose) administered once a day for 14 days.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Endothelial dependent vasodilatation in the brachial artery measured by magnetic resonance imaging</outcome>
      <timepoint>outcome measured after day 14.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>myocardial blood flow measured on cardiac magnetic resonance imaging</outcome>
      <timepoint>outcome measured after day 14.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>aortic distensibility measured on cardiac magnetic resonance imaging.</outcome>
      <timepoint>outcome measured after day 14</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>stable angina</inclusivecriteria>
    <inclusiveminage>50</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>renal failure, unsuitable for Magnetic Resonance Imaging</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>central randomization by central pharmacy</concealment>
    <sequence>computerized sequence generation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2 / Phase 3</phase>
    <anticipatedstartdate>2/01/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>5042</postcode>
    <postcode>5000</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>Department of Health</primarysponsorname>
    <primarysponsoraddress>Southern Adelaide Health Service,
Government of South Australia</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Flinders University</fundingname>
      <fundingaddress>Bedford Park
Adelaide</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Department of Cardiology
Royal Adelaide Hospital</othercollaboratorname>
      <othercollaboratoraddress>Adelaide</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of the study is to evaluate the effect of tetrahydrobiopterin (BH4) on myocardial blood flow and vascular function in patients with coronary artery disease.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Flinders Clinical Research Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry />
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Human Ethics Committee- Royal Adelaide Hospital</ethicname>
      <ethicaddress>Adelaide</ethicaddress>
      <ethicapprovaldate>6/12/2007</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Biju Paul</name>
      <address>Department of Medicine
Flinders Medical Centre
Adelaide</address>
      <phone>0882045972</phone>
      <fax />
      <email>paul0075@flinders.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Biju Paul</name>
      <address>Department of Medicine
Flinders Medical Centre
Adelaide</address>
      <phone>0882045972</phone>
      <fax />
      <email>paul0075@flinders.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Biju Paul</name>
      <address>Department of Medicine
Flinders Medical Centre
Adelaide</address>
      <phone>0882045972</phone>
      <fax />
      <email>paul0075@flinders.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>